Clinical trials are being conducted to study the use of a delayed release drug for the treatment of HG.
To Participate you must meet certain criteria listed below:
Singleton pregnancy of less than 7 weeks gestation.
Women who previously carried a full term pregnancy.
Severe NVP/HG in previous pregnancy by verbal confirmation as determined by questionnaire
Women who refuse to participate in the study/sign a written concent
Women with insufficient English language skills to understand the questionnaires and assessment material
Women in her first pregnancy
Women who didn’t suffer severe NVP/HG in previous pregnancy
Gestational age beyond 7w+0d weeks of pregnancy
Women who have had previous adverse effects to “Diclectin®”
Women who take another anti-emetic medication
Pregnant women younger than 18 years.
See the link above for more detailed description of the clinical trial.